Having a preexisting autoimmune disease is an independent risk factor for poor outcomes with myelodysplastic syndrome (MDS), according to a study published in the June issue of Clinical Immunology.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗